In vitro and physiologically‐based pharmacokinetic based assessment of drug–drug interaction potential of canagliflozin-Reference-Cited by-同舟云学术

In vitro and physiologically‐based pharmacokinetic based assessment of drug–drug interaction potential of canagliflozin

Published:2016-12-20 Issue:5 Volume:83 Page:1082-1096
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Mamidi Rao N. V. S.¹,Dallas Shannon²,Sensenhauser Carlo²,Lim Heng Keang²,Scheers Ellen³,Verboven Peter³,Cuyckens Filip³,Leclercq Laurent³,Evans David C.²,Kelley Michael F.²,Johnson Mark D.¹,Snoeys Jan³

Affiliation:

1. Preclinical Development & SafetyJanssen Research & Development, LLC Raritan New Jersey USA

2. Preclinical Development & SafetyJanssen Research & Development, LLC Spring House Pennsylvania USA

3. Preclinical Development & SafetyJanssen Research & Development Beerse Belgium

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13186

Reference27 articles.

1. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

2. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

3. The Concise Guide to PHARMACOLOGY 2015/16: Transporters

4. Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co‐Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus

5. Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Warfarin–A natural anticoagulant: A review of research trends for precision medication;Phytomedicine;2024-06

2. Prediction of Drug–Drug Interactions with Ensartinib as a Time-Dependent CYP3A Inhibitor Using Physiologically Based Pharmacokinetic Model;Drug Metabolism and Disposition;2023-08-29

3. Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications;Metabolites;2023-07-29

4. In vivo assessment of the pharmacokinetic interactions between donafenib and dapagliflozin, donafenib and canagliflozin in rats;Biomedicine & Pharmacotherapy;2023-06

5. Interaction between Chinese medicine and digoxin: Clinical and research update;Frontiers in Pharmacology;2023-02-07